75 related articles for article (PubMed ID: 11062016)
1. PPARalpha-dependent alteration of GRP94 expression in mouse hepatocytes.
Macdonald N; Barrow K; Tonge R; Davison M; Roberts RA; Chevalier S
Biochem Biophys Res Commun; 2000 Nov; 277(3):699-704. PubMed ID: 11062016
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive gene expression analysis of peroxisome proliferator-treated immortalized hepatocytes: identification of peroxisome proliferator-activated receptor alpha-dependent growth regulatory genes.
Tien ES; Gray JP; Peters JM; Vanden Heuvel JP
Cancer Res; 2003 Sep; 63(18):5767-80. PubMed ID: 14522898
[TBL] [Abstract][Full Text] [Related]
3. Tumour necrosis factor alpha (TNFalpha): role in suppression of apoptosis by the peroxisome proliferator nafenopin.
Holden PR; Hasmall SC; James NH; West DR; Brindle RD; Gonzalez FJ; Peters JM; Roberts RA
Cell Mol Biol (Noisy-le-grand); 2000 Feb; 46(1):29-39. PubMed ID: 10726969
[TBL] [Abstract][Full Text] [Related]
4. Regulation of apoptosis by peroxisome proliferators.
Roberts RA; Michel C; Coyle B; Freathy C; Cain K; Boitier E
Toxicol Lett; 2004 Apr; 149(1-3):37-41. PubMed ID: 15093246
[TBL] [Abstract][Full Text] [Related]
5. Diminished hepatocellular proliferation in mice humanized for the nuclear receptor peroxisome proliferator-activated receptor alpha.
Cheung C; Akiyama TE; Ward JM; Nicol CJ; Feigenbaum L; Vinson C; Gonzalez FJ
Cancer Res; 2004 Jun; 64(11):3849-54. PubMed ID: 15172993
[TBL] [Abstract][Full Text] [Related]
6. Mouse hepatocyte response to peroxisome proliferators: dependency on hepatic nonparenchymal cells and peroxisome proliferator activated receptor alpha (PPARalpha).
Hasmall S; James N; Hedley K; Olsen K; Roberts R
Arch Toxicol; 2001 Aug; 75(6):357-61. PubMed ID: 11570693
[TBL] [Abstract][Full Text] [Related]
7. Peroxisome proliferator-activated receptor-alpha mice show enhanced hepatocyte proliferation in response to the hepatomitogen 1,4-bis [2-(3,5-dichloropyridyloxy)] benzene, a ligand of constitutive androstane receptor.
Columbano A; Ledda-Columbano GM; Pibiri M; Concas D; Reddy JK; Rao MS
Hepatology; 2001 Aug; 34(2):262-6. PubMed ID: 11481610
[TBL] [Abstract][Full Text] [Related]
8. Cell cross-talk mediates PPARalpha null hepatocyte proliferation after peroxisome proliferator exposure.
Weglarz TC; Sandgren EP
Carcinogenesis; 2004 Jan; 25(1):107-12. PubMed ID: 14514660
[TBL] [Abstract][Full Text] [Related]
9. Regulation of cell proliferation and cell death by peroxisome proliferators.
Cattley RC
Microsc Res Tech; 2003 Jun; 61(2):179-84. PubMed ID: 12740824
[TBL] [Abstract][Full Text] [Related]
10. Suppression of mouse hepatocyte apoptosis by peroxisome proliferators: role of PPARalpha and TNFalpha.
Hasmall SC; James NH; Macdonald N; Gonzalez FJ; Peters JM; Roberts RA
Mutat Res; 2000 Mar; 448(2):193-200. PubMed ID: 10725472
[TBL] [Abstract][Full Text] [Related]
11. Induction of the expression of the peroxisome proliferator-activated receptor alpha (PPARalpha) by clofibrate in jerboa tissues.
Amsaguine-Safir S; Bianchi A; Collet P; Huin-Schohn C; Jeanvoine A; Bécuwe P; Krémarik-Bouillaud P; Domenjoud L; Keller JM; Schohn H; Dauça M
Microsc Res Tech; 2003 Jun; 61(2):185-90. PubMed ID: 12740825
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the effects of various peroxisome proliferators on peroxisomal enzyme activities, DNA synthesis, and apoptosis in rat and human hepatocyte cultures.
Goll V; Alexandre E; Viollon-Abadie C; Nicod L; Jaeck D; Richert L
Toxicol Appl Pharmacol; 1999 Oct; 160(1):21-32. PubMed ID: 10502499
[TBL] [Abstract][Full Text] [Related]
13. Liver gene expression in rats in response to the peroxisome proliferator-activated receptor-alpha agonist ciprofibrate.
Yadetie F; Laegreid A; Bakke I; Kusnierczyk W; Komorowski J; Waldum HL; Sandvik AK
Physiol Genomics; 2003 Sep; 15(1):9-19. PubMed ID: 12851464
[TBL] [Abstract][Full Text] [Related]
14. Quantitative proteomic analysis of mouse liver response to the peroxisome proliferator diethylhexylphthalate (DEHP).
Macdonald N; Chevalier S; Tonge R; Davison M; Rowlinson R; Young J; Rayner S; Roberts R
Arch Toxicol; 2001 Sep; 75(7):415-24. PubMed ID: 11693183
[TBL] [Abstract][Full Text] [Related]
15. Regulation of phase I and phase II steroid metabolism enzymes by PPAR alpha activators.
Fan LQ; You L; Brown-Borg H; Brown S; Edwards RJ; Corton JC
Toxicology; 2004 Nov; 204(2-3):109-21. PubMed ID: 15388238
[TBL] [Abstract][Full Text] [Related]
16. Peroxisome proliferator-activated receptor alpha protects against alcohol-induced liver damage.
Nakajima T; Kamijo Y; Tanaka N; Sugiyama E; Tanaka E; Kiyosawa K; Fukushima Y; Peters JM; Gonzalez FJ; Aoyama T
Hepatology; 2004 Oct; 40(4):972-80. PubMed ID: 15382117
[TBL] [Abstract][Full Text] [Related]
17. Heat shock protein-90 (Hsp90) acts as a repressor of peroxisome proliferator-activated receptor-alpha (PPARalpha) and PPARbeta activity.
Sumanasekera WK; Tien ES; Davis JW; Turpey R; Perdew GH; Vanden Heuvel JP
Biochemistry; 2003 Sep; 42(36):10726-35. PubMed ID: 12962497
[TBL] [Abstract][Full Text] [Related]
18. Role of the peroxisome proliferator-activated receptor alpha (PPARalpha) in responses to trichloroethylene and metabolites, trichloroacetate and dichloroacetate in mouse liver.
Laughter AR; Dunn CS; Swanson CL; Howroyd P; Cattley RC; Corton JC
Toxicology; 2004 Oct; 203(1-3):83-98. PubMed ID: 15363585
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of lactoferrin by PPARalpha ligands: role in perturbation of hepatocyte proliferation and apoptosis.
Hasmall S; Orphanides G; James N; Pennie W; Hedley K; Soames A; Kimber I; Roberts R
Toxicol Sci; 2002 Aug; 68(2):304-13. PubMed ID: 12151626
[TBL] [Abstract][Full Text] [Related]
20. Peroxisome proliferator-activated receptor-alpha regulates postischemic liver injury.
Okaya T; Lentsch AB
Am J Physiol Gastrointest Liver Physiol; 2004 Apr; 286(4):G606-12. PubMed ID: 14615282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
